European Primary Care Cardiovascular Society

Lipids

Inverse association between long-term statin adherence and all-cause mortality in ASCVD

Literature - Feb. 20, 2019 - Rodriguez F et al. - JAMA Cardiol 2019
A retrospective cohort study found that low adherence to long-term statin therapy was associated with a higher risk of all-cause mortality in patients with ASCVD.

A retrospective cohort study found that low adherence to long-term statin therapy was associated with a higher risk of all-cause mortality in patients with ASCVD.

Efficacy of statins in primary CVD prevention confirmed in large meta-analysis, but individual benefit-harm profiles vary

Literature - Feb. 19, 2019 - Yebyo HG et al. - Am Heart J 2019

This meta-analysis of RCTs on statins demonstrated reduced risk of most CVD outcomes in primary prevention populations, with increased risk of some side effects. A network meta-analysis revealed different benefit-harm profiles for specific statins.

In older individuals statins result in large reduction of major vascular events

Literature - Feb. 11, 2019 - Cholesterol Treatment Trialists’ Collaboration - The Lancet 2019

A meta-analysis of 28 large RCTs including more than 14.000 individuals aged >75 years showed that the use of statins resulted in significant reductions of major vascular events regardless of age.

EPCCS

European Primary Care Cardiovascular Society

3' education - Feb. 8, 2019

Learn more about the activities of EPCCS that are aimed at supporting primary care professionals manage their patients with cardiovascular and cardiometabolic disease.

Measuring Lp(a) levels leads to better characterization of ASCVD risk in children with FH

Literature - Jan. 7, 2019 - Zawacki et al. - J Clini Lipidol 2018

A retrospective review showed that children with FH and family history of early-onset ASCVD were more likely to have Lp(a) ≥50 mg/dL, compared with children with FH and family history of late-onset ASCVD.

The cardiovascular challenge for primary care in diabetes

10' education - July 10, 2018 - Prof. Richard Hobbs - Oxford, UK
Prof. Hobbs stresses  the importance of CVRM in primary care and how to manage this risk beyond glucose control.

Prof. Hobbs stresses the importance of CVRM in primary care and how to manage this risk beyond glucose control.

Slides | Take home messages of EPCCS Guidance on 'Managing elevated lipids in primary care'

EPCCS Guidance

Download - Dec. 18, 2018
Slides with take home messages of our EPCCS Practical Guidance Document, which provides practical guidance on management of persons with dyslipidaemia in primary care, with a focus on challenges faced in clinical reality.

Slides with take home messages of our EPCCS Practical Guidance Document, which provides practical guidance on management of persons with dyslipidaemia in primary care, with a focus on challenges faced in clinical reality.

New cholesterol guidelines: aim therapy at patients at highest risk who will benefit most

AHA 2018 - Chicago, IL, USA

3' education - Nov. 22, 2018 - Neil Stone, MD - Evanston and Chicago, IL, USA
Neil Stone served as vice-president of the new cholesterol guideline. He sums up the main new recommendations based on the latest evidence of recent lipid outcome trials.

AHA 2018 Neil Stone served as vice-president of the new cholesterol guideline. He sums up the main new recommendations based on the latest evidence of recent lipid outcome trials.

2018 Guidelines on the management of cholesterol: take home messages

News - Nov. 16, 2018

AHA 2018 The American Heart Association (AHA) and the American College of Cardiology (ACC) updated the 2018 cholesterol guidelines. A summary of key recommendations concerning cholesterol management in de prevention of CVD.

Prevention of atherosclerotic CV events with cholesterol absorption inhibitor in older patients

AHA 2018 – Chicago, IL, USA

News - Nov. 13, 2018

AHA 2018 In Japanese patients aged ≥75 years with elevated LDL-c levels, ezetimibe results in prevention of atherosclerotic CV events, as shown in the EWTOPIA75 randomized trial.

More focus on personalized risk assessment in updated AHA/ACC cholesterol guidelines

AHA 2018 – Chicago, IL, USA

News - Nov. 13, 2018

AHA 2018 The updated cholesterol guidelines help physicians to personalize treatment based on risk assessment, and now include CAC measurement to guide treatment decisions in certain patients.

Intensive lifestyle intervention program associated with reduced CV risk in overweight/obese adults

Literature - Nov. 9, 2018 - Salas-Salvadó J et al. - Diabetes Care 2018

In this randomized trial, the long-term intensive PREDIMED-Plus lifestyle intervention resulted in weight loss and reduced CV risk in overweight/obese adults with metabolic syndrome, compared to standard care.